期刊文献+

白果内酯治疗大鼠卡氏肺孢子虫肺炎后的形态学变化 被引量:2

Pathological changes in lungs of rats infected with Pneumocystis carinii pneumonia after treatment with bilobalide
下载PDF
导出
摘要 目的:研究经白果内酯治疗后卡氏肺孢子虫肺炎(PCP)大鼠的肺部病理学变化。方法:以地塞米松连续6周皮下注射Wistar大鼠,建立卡氏肺孢子虫肺炎动物模型,腹腔内注射白果内酯30mg/(kg.d)×8天,停药1周后杀鼠取肺,光镜和电镜观察大鼠肺部病理学变化,同时设有感染对照组和正常对照组。结果:经白果内酯治疗后肺印片中卡氏肺孢子虫(Pc)包囊数显著减少,肺部炎症明显吸收。透射电镜观察Ⅰ型肺泡上皮细胞水肿明显减轻,肺孢子虫滋养体大量空泡形成、细胞器肿胀破坏,髓样结构形成、胞膜破坏和胞质内出现一些电子密度较高的颗粒。结论:白果内酯可杀死卡氏肺孢子虫,经白果内酯治疗后肺部炎症减轻。 Objective:To study the Pathological changes in lungs of rats infected with Pneumocystis carinii pneumonia after treatment with bilodalide (BL). Methods:PCP rat models were established of hypodermic injection of dexamethasone twice a week for 6 weeks. The PCP rats were treated with BL 30mg/ (kg·d)× 8days and killed to obtain lungs. Pathological changes in lung tissues were observed under light and electron microscope .Infected and normal rats were established as controls. Results: The number of Pc cysts was markedly reduced in the lung print smear and inflammation in the lung was lightened. The investigation of thinner lung tissue section by transmission electronic microscope Showed that the Pneumocystis carinii treated with bilobalide had formation of vacuoles in trophozoites,swelling and destroying of cell organ, rupture of cytomembrane and some high density electronic granulae were investigated in the cytoplasm. Membrane of cyst was destroyed too. Conclusion:Bilodalide can kill Pc and alleviate inflammation in the lung tissues of PCP rats.
出处 《重庆医科大学学报》 CAS CSCD 2007年第3期243-246,302,共5页 Journal of Chongqing Medical University
基金 国家自然科学基金资助(30070680)。
关键词 白果内酯 卡氏肺孢子虫肺炎 病理学 超微结构 Bilobalide Pneumocystis carinii pneumonia Pathological Ultrastructure
  • 相关文献

参考文献5

二级参考文献21

  • 1姚渭溪.银杏叶中活性成分的提取工艺、测定及其进展[J].中草药,1995,26(3):157-159. 被引量:107
  • 2陈雅棠,刘约翰,沈际琨,唐宜,王小根.大鼠肺孢子虫肺炎动物模型建立及病原学病理学观察[J].重庆医科大学学报,1989,14(3):181-183. 被引量:20
  • 3营佳.银杏叶药用研究概况[J].中国生化药物杂志,1996,17(1):44-46. 被引量:13
  • 4陈仲良.银杏提取物的化学成分和制剂的质量[J].中国药学杂志,1996,31(6):326-331. 被引量:102
  • 5[1]Powel Kazanjian, Wendy Armstrong, Paul A. Hossler, et al. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients[J]. JID,2000,182(8):551-557.
  • 6[4]Cushion M T, Collins M, Hazra B, et al. Effects of atovaquone and diospyrin-based drugs on the cellular ATP of Pneumocystis carinii f. sp. Carinii[J]. Antimicrob Agents Chemother, 2000, 44(3):713-719.
  • 7[5]Ito M, Nozu R, Kuramochi T. Prophylactic effect of FK463, a novel antifungal lipopeptide, against Pneumocystis carinii infection in mice[J]. Antimicrob Agents Chemother, 2000, 44(9):2259-2262.
  • 8[6]Kim C K, Foy J M, Cushion M T, et al. Comparison of histologic and quantitative techniques in evalution of therapy for experimental Pneumocystis carinii pneumonia[J]. Antimicrob Agents Chemother, 1987,31(2):197-201.
  • 9[7]Atzori C, Bruno A, Chichino G, et al. Activity of Bilobalide, a Sesquiterpene from Ginkgo biloba, on Pneumocystis carinii[J]. Antimicrob Agents Chemother, 1993,37(7):1492-1496.
  • 10陈雅棠,重庆医科大学学报,1989年,3卷,14期,181页

共引文献45

同被引文献37

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部